Skip to main content

New funding scheme: £4M available for proposals to establish infrastructure needed to accelerate use of non-animal methods. Apply now.

NC3Rs | 20 Years: Pioneering Better Science
Webinar and video

Microsampling in toxicology – Maximising the scientific, business and 3Rs advantages

This webinar was held in September 2022 in collaboration with the British Toxicology Society (BTS). Its aim is to raise awareness of the microsampling technique and encourage wider adoption across both discovery and regulatory toxicology studies. 

This was a ‘re-run’ of a session presented during the 2022 BTS congress to make the content accessible to the wider scientific community around the world. 

Read more about our work on microsampling on our resource page.

Preclinical to clinical use of microsamples - start small, stay small (Dr Neil Spooner, Bioanalytical Solutions Ltc)


Current use, 3Rs benefits and barriers for microsampling: 2021 cross-sector survey results (Dr Helen Prior, NC3Rs)

In 2020 we initiated an industry survey to establish how widely microsampling was used within the pharmaceutical and agrochemical industries. This presentation outlines some of the results.


Is microsampling applicable for large molecules and other drug modalities? (Dr Amanda Wilson, AstraZeneca)


Incorporating microsampling for agrochemical TK data to improve risk assessment (Dr Derek Angus, Syngenta)


Microsampling of main test animals without detriment to clincial pathology parameters (Carol Strepka, Charles River Laboratories)


Animal welfare benefits of microsampling for any purpose (Dr Hollie Blunt, Sequani)